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Aging is a complex process associated with various 
molecular modifications in cells including epigenetic 
transitions that create changes in gene expression. Many 
studies have indicated DNA methylation (DNAmet) is 
an important component of aging. In addition to  inherit- 
 
ed, genetically driven DNAmet changes, a broad 
spectrum of environmental factors can influence the 
methylation status of many sites making the human 
DNA methylome a sensitive marker set of epigenetic 
drift rather than a stable imprint [1, 2, 3]. Therefore, age 
predicted with epigenetic markers better reflects the 
biological age than the chronological age of an indivi-
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Recent progress  in epigenomics has  led  to  the development of prediction  systems  that enable accurate age
estimation  from DNA methylation data. Our objective was  to  track  responses  to  intense physical exercise of
individual age‐correlated DNA methylation markers and to infer their potential impact on the aging processes.
The study showed accelerated DNA hypermethylation  for  two CpG sites  in TRIM59 and KLF14. Both markers
predicted  the  investigated  elite  athletes  to  be  several  years  older  than  controls  and  this  effect was more
substantial  in  subjects  involved  in  power  sports.  Accordingly,  the  complete  5‐CpG  model  revealed  age
acceleration  of  elite  athletes  (P=1.503x10‐7)  and  the  result  was  more  significant  amongst  power  athletes
(P=1.051x10‐9). The modified methylation of TRIM59 and KLF14  in  top athletes may be accounted  for by  the
biological roles played by these genes. Their known anti‐tumour and anti‐inflammatory activities suggests that
intense physical  training has a  complex  influence on aging and potentially  launches  signalling networks  that
contribute to the observed lower risk of elite athletes to develop cardiovascular disease and cancer. 
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dual and such differences in aging rates may potentially 
be linked to various clinical and environmental factors.  
 
With the advent of high-throughput sequencing 
technologies epigenome-wide association studies 
became available and led to successful identification of 
age-correlated DNAmet changes [1, 2, 4–8]. These 
discoveries were associated with development of age 
prediction models that have allowed unprecedented 
accuracy for age estimation regimes. Epigenetic age 
prediction methods have been mostly developed based 
on DNA extracted from blood but other DNA sources 
have also been investigated [9]. The studies of age-
related DNAmet markers have also revealed that age 
acceleration defined as the discrepancy between methy-
lation age and chronological age, may be a reliable 
indicator of increased disease and mortality risk [10, 11, 
12, 13]. Since age acceleration can be a biologically 
meaningful biomarker, knowledge of its progression 
may find practical application in many disciplines 
including sports medicine and forensics [14, 15].  
 
It is widely accepted that people who engage in 
moderate physical activity will benefit from better 
mood and cognition, lower levels of cardiovascular 
disease and a slower rate of aging [16, 17]. Indeed, the 
bulk of research has reported longer life expectancy and 
lower mortality risk for elite athletes compared to the 
general population and such results are particularly 
consistent for groups of endurance athletes. Results 
from several large meta-analyses are the most 
informative [18-20]. Investigating the epigenome of 
elite athletes provides a potentially informative way to 
study how life-style can affect the functioning of the 
human genome. Moreover, it has been shown that 
DNAmet in various CpG sites may undergo diverse 
regulation [21]. Thus, the tracking of individual 
epigenetic markers may provide better insight into the 

















the cellular activity and potential interactions the key 
genes are involved in. The possibility to examine more 
closely the molecular processes associated with aging 
from the advent of epigenomic analysis and epigenetic 
age prediction, permits more objective exploration of 
the role of physical activity in a healthy lifestyle.  
 
Our study aimed to examine whether intense physical 
exercise can alter DNAmet profiles and lead to changes 
in the rate of aging. To do this we studied the DNAmet 
profile of Polish professional athletes at 5 CpG sites in 
five different genes that we had previously selected and 
developed into a DNAm-based age prediction calculator 
[22]. The study intended to distinguish markers 
following a regular clock-like pattern of methylation 
change from those sites more prone to environmental 




DNA methylation status at the 5 CpG sites in five age 
related genes was analyzed in 176 athletes, in 
comparison to 128 healthy control individuals from the 
general population matched by age (P=0.760) and 
gender (P=0.949). Elite athletes comprised young 
individuals with a mean age of 24.1 and was 112 males 
(63.6%) and 64 females (36.4%); as outlined in Table 1. 
The group of power athletes consisted of 57 males 
(60.6%) and 37 females (39.4%) and had a mean age of 
23 years. The group of endurance athletes comprised 55 
males (67.1%) and 27 females (32.9%) with a mean age 
of 25.2 years. The control group had a mean age of 24.2 
and was 81 males (63.3%) and 47 females (36.7%). Age 
distribution graphs for athletes and controls by gender 
are provided in Supplementary Figure 1. The mean age 
of males in the group of athletes was higher (24.9) 
compared to females (22.7); and similarly in the control 


























Controls Endurance Controls Power Controls 
ELOVL2 C7 60.89 61.09 0.791 61.94 61.09 0.342 59.98 61.09 0.196 
MIR29B2C C1 79.43 80.54 0.113 80.04 80.54 0.542 78.89 80.54 0.058 
FHL2 C2 36.37 35.87 0.375 36.41 35.87 0.453 36.33 35.87 0.465 
TRIM59 C7 31.43 28.19 1.894x10-7 30.56 28.19 0.004 32.18 28.19 2.946x10-7 
KLF14 C1 5.16 4.12 8.974x10-10 5.23 4.12 1.866x10-7 5.10 4.12 4.987x10-7 
Significant values are marked in bold. 
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DNA methylation status 
 
The study revealed significantly altered DNA 
methylation patterns between the whole group of 
athletes and controls in TRIM59 (P=1.894x10-7) and 
KLF14 (P=8.974x10-10), as well as separately for 
endurance and power athletes (Table 1). Although the 
results were significant for both endurance and power 
athletes, a more marked difference was noted in 
TRIM59 C7 for the power athletes (P=2.946x10-7). In 
KLF14 C1, hypermethylation was observed for power 
and endurance athletes with a similar level of 
significance of P=4.987x10-7 and P=1.866x10-7, 
respectively (Table 1). Analyses performed separately 
for females and males confirmed TRIM59 and KLF14 
markers to be significantly hypermethylated in athletes 








































Age prediction and age acceleration 
 
Table 2 shows that our established multivariate 5-CpG 
ANN model predicted the whole group of elite athletes 
with a lower accuracy of MAE = 3.3, compared to 
healthy controls of similar mean age and age 
distribution that had a MAE = 2.4, P = 3.815x10-4. 
When the two athlete groups were analysed separately, 
a significant decrease of age prediction accuracy from 
MAE=2.4 to MAE = 3.7 was only found for power 
athletes (P=5.727x10-5). Analyses performed separately 
for females and males confirmed reduced accuracy of 
age prediction in the group of power athletes vs. 
controls in both genders (P=0.013 and P=0.002, for 
females and males respectively); outlined in 










































Model Compared groups N MAE Std. Deviation P value 
5 CpG model [22] Athletes 175 3.273 2.620 3.815x10-4 
Controls 128 2.361 1.797 
Endurance 82 2.776 2.391 0.180 
Controls 128 2.361 1.797 
Power 93 3.712 2.745 5.727x10-5 
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Age acceleration from chronological and methylation 
age divergence (determined using the 5-CpG model) 
was further calculated and tested for its association with 
intense physical exercise. This analysis showed the 
status of elite athletes is significantly associated with 
age acceleration (P=1.503x10-7) and was significant for 
both groups (1.051x10-9 and 0.004 for power and 
endurance athletes, respectively; Table 3). Analysis 
performed at the level of single CpG predictors showed 
that significant association of the status of elite athletes 
with age acceleration arose from increased DNA 
methylation of the CpGs at TRIM59 and KLF14. The 
level of significance of association between the status of 
power athletes and age acceleration was highest when 










































10-10 comparing to P=0.003 obtained for endurance 
athletes), but at a comparable level in KLF14 in both 
groups (P=3.345x10-7 and P=2.116x10-8, for endurance 
and power groups, respectively). The type of sport 
competition performed was also found to be 
significantly associated with age acceleration (P=0.003) 
indicating the increased aging of athletes engaged in 
power sports compared to endurance sports (Table 3).  
 
Predicted age versus chronological age in endurance 
and power athletes plus the group of controls is 
presented on Figure 1, which shows predictions based 
on the 5-CpGs model and TRIM59 and KLF14 sepa-
rately. Figure 2 shows that age prediction based on CpG 










































Models Age acceleration (5 CpGs 
model) 
Age acceleration (KLF14 C1) Age acceleration (TRIM59 C7) 
Effect 
size* 
SE P value Effect 
size* 
SE P value Effect 
size* 
SE P value 
Athletes vs. 
Controls 
2.156 0.401 1.503x10-7 5.559 0.845 2.111x10-10 4.629 0.834 6.270x10-8 
Endurance vs. 
Controls 
1.329 0.452 0.004 5.478 1.039 3.345x10-7 2.647 0.867 0.003 
Power vs. Controls 2.885 0.452 1.051x10-9 5.630 0.968 2.116x10-8 6.194 0.917 1.239x10-10 
Power vs. 
Endurance 
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5.5 years older than healthy controls (P=1.766x10-9), 
endurance athletes to be 5.9 years older than controls 
from the general population (P=2.511x10-7) and power 
athletes to be 5.1 years older than healthy controls 
(P=8.443x10-7). Age prediction performed with DNA 
methylation values from CpG site C7 in TRIM59 
showed athletes to be an average 4.5 years older than 
healthy controls (P=9.405x10-8), power athletes to be 
5.6 years older than healthy controls (P=2.105x10-7) 
while endurance athletes were predicted to be 3.3 years 




The impact of physical exercises on epigenetic age 
 
Very intensive physical exercise as a routine part of 
elite athlete training has been shown to have favorable 
effects on lifespan longevity and is associated with a 
lowered risk of cardiovascular diseases and cancer in 
later life [19, 20, 24]. Importantly, individuals with 
active lifestyles but free from the stress of extreme 
exercise regimes benefit from regular physical activity 
by reducing their risk of all forms of mortality, and in 
proportion to the intensity of the training [25]. Better 
insight into the molecular processes behind the aging of 
elite athletes is now possible thanks to recent advances 
in epigenetics and the efficiency of DNAmet age 
prediction systems in providing reliable indicators of 
the aging rate. Our study indicates accelerated aging of 
the whole group of elite athletes, with power athletes 
shown to have higher levels of age acceleration 
compared to endurance athletes. The observed accelera-
tion of aging may potentially have significant 
implications, as it has been shown that a difference 
between the chronological age of an individual and the 
age measured by DNA methylation is an indicator of a 
person’s overall condition and is predictive of mortality 
in later life.  
 
The meaning of epigenetic age 
 
The epigenetic clock CpGs defined as correlated with 
age consistently between individuals and included in 
various age prediction models, reveal some degree of 
inter-individual variability [26]. There is an on-going 
debate about the real meaning of age measured by 
DNAmet status. The picture arising from recent 
research indicates that various markers included in age 
estimation models may be regulated in a different way. 
Particular age-correlated CpGs could be liable to 
moderation by inherited factors and the environment 
[2]. It has been shown that the epigenetic clock 
developed by Horvath can also measure age in non-
proliferative tissues but at the same time there is 
evidence that hypermethylation of one of the most 
informative age predictors – ELOVL2, is associated 
with cell replications and thus indicates a mitotic age 
[21]. Therefore, it is conceivable that some DNAmet 
markers may be more sensitive to the environment than 
others and consequently they can provide a better 
measure of epigenetic drift. Consequently, it is 
unsurprising that not all age predictors are informative 
in terms of increased mortality risk. The study of Lin et 
al selected 37 CpGs indicative of life expectancy from 
their full set of 99 markers. Additionally, they tested 
alternative age prediction models and found that the 
marker sets proposed by Horvath and Hannum 
contained mortality sensitive CpG sites [12, 1, 2]. Two 
out of five markers investigated here, namely TRIM59 
and KLF14, are among the suggested life expectancy-
sensitive markers from the Hannum model. TRIM59 
belongs to the ten most informative markers from the 
age predictors included in that age prediction model 
[12]. Notably, an independent study has demonstrated 
that 5-year higher DNA methylation age predicted by 
the Hannum model was associated with a 21% 
increased mortality risk [11]. Overall, multiple studies 
have reported an 11% to 35% increase in mortality risk 
for individuals with a 5-year higher DNA methylation 
age [11, 12, 27]. Recently, Zhang et al presented a list 
of life expectancy DNA methylation markers which are 
independent from the epigenetic clock, providing 
further evidence that aging related markers can be 
different from markers predicting chronological age 
[13]. 
 
The molecular role of individual age-correlated DNA 
methylation markers  
 
More detailed analysis of the accelerated aging of elite 
athletes indicated by our model revealed that 
accelerated hypermethylation of TRIM59 and KLF14 
were the principal cause of the changes. Both, are 
widely replicated age predictors used in various age 
estimation models based on DNA methylation analysis 
[2, 22, 28, 29]. Most studies have indicated longer life 
expectancy in top athletes compared to the general 
population and our finding of an accelerated epigenetic 
age of elite athletes seems to contradict these results. 
However, careful inspection of the molecular nature of 
TRIM59 and KLF14 might reveal their specific impact 
on aging processes in these athletes. TRIM59 has 
recently emerged as a powerful oncogene involved in 
induction of cellular senescence. Valiyeva and collea-
gues have shown that TRIM59 can affect Ras and RB 
signal pathways and its knockdown leads to S-phase 
cell cycle arrest and cell growth retardation [30]. 
Importantly, it has been shown that interaction between 
Ras and pRb may launch cellular processes leading to 
cellular senescence and tumor suppression [31]. There 
is growing evidence that TRIM59 is a promoter of cell 
www.aging‐us.com  246  AGING 
proliferation and migration. Increased expression of this 
gene has been reported in various tumors [32 – 35]. In 
contrast to the initial perception that cellular senescence 
is harmful, it has been proposed to have beneficial 
biological implications. Cellular senescence acts as a 
tumour-suppressive mechanism that irreversibly blocks 
cellular proliferation in response to stress and through 
this process, creates a barrier to the development and 
progression of cancer. Moreover, this apparent cancer 
moderation is accompanied by the acquisition of a 
senescence-associated secretory phenotype that induces 
cell plasticity which is important in tissue regeneration 
or wound healing [36]. Thus, hypermethylation of 
TRIM59 indicates accelerated aging of elite athletes, 
especially involved in power sports but at the same time 
it may have an anticancer effect. Interestingly, a study 
of mutants in the p53 tumor suppressor gene has shown 
that increased tumor protection occurs from modified 
p53 protein, while at the same time these induce early 
onset aging in mice; linking senescence, aging and 
cancer [37]. Our previous study revealed aberrant 
hypermethylation of TRIM59 in early-onset 
Alzheimer’s disease patients and in Graves’ disease 
patients [23]. This seems to further support the 
hypothesis of the involvement of TRIM59 in cellular 
senescence since chronic neuro-inflammation has been 
shown to be important in aging and neuro-degeneration, 
while autoimmunity is known to induce inflammation, 
tissue damage and remodelling [38, 39]. 
 
The observed hypermethylation of KLF14 also indicates 
accelerated aging of elite athletes. Recent findings 
showing the role of KLF14 in chronic inflammatory 
responses and the pathogenesis of atherosclerosis may 
be particularly relevant to this finding [40, 41]. Wei et 
al showed that KLF14 may be involved in induction of 
inflammation and for this reason knockdown of this 
gene reduces pro-inflammatory cytokines and the 
formation of atherosclerotic lesions. This anti-
inflammatory effect was suggested to prevent 
atherosclerosis: a known chronic inflammatory disease 
[40]. It is interesting to speculate whether DNA 
methylation of TRIM59 is involved in the process of 
cellular senescence and the associated beneficial 
biological effects. Similarly, the hypermethylation of 
KLF14 could have an anti-inflammatory role preventing 
cardiovascular disease. These hypotheses deserve 
further investigation, but they may already explain the 
increased life expectancy of elite athletes and in 
particular, the lower risk they have to develop cancer 




Our study findings indicate various  age  predictors  can  
show detectable differences in sensitivity to intense 
physical activity. The study revealed accelerated 
hypermethylation of TRIM59 and KLF14 in elite 
athletes suggesting their higher epigenetic age, which is 
contrary to epidemiological data showing longer life 
duration of athletes. However, the two genes are 
involved in anti-tumor and anti-inflammatory activities, 
respectively, which in turn could affect better life-
expectancy. The results obtained may reveal a complex 
influence of intense physical training on the aging 
process. We speculate that the resulting diminished 
expression of these genes may potentially launch 
signaling networks that contribute to an observed lower 
risk for elite athletes to develop cardiovascular disease 
and cancer.  
 
Investigation of an extended list of age-related markers 
and detailed analyses of the relevance of individual 
CpGs for biological aging will aid in the understanding 
of the role of DNA methylation in human aging and an 
assessment of the relevance of DNA methylation as an 
indicator of the condition of an individual.  
 
MATERIALS AND METHODS 
 
Samples and analysis of DNA methylation 
 
The study was approved by the Ethics Committee of the 
Józef Piłsudski University of Physical Education in 
Warsaw (SKE 01-50/2012) and the institutional ethical 
review board of the Ethics Committee of Investigation 
in Galicia, Spain (CAEI: 2013/543). Written informed 
consent was obtained from the elite athletes and 
counterpart controls from the general population 
forming the study subjects. Peripheral blood was 
collected in EDTA tubes from 176 elite athletes in the 
years 2010-2014. Chronological age at the time of 
blood collection was used for all the calculations in this 
study. Top-level professionals (including medallists of 
Olympic Games and World championships) in power 
and endurance sports, 100 athletics, 21 speed skaters, 28 
swimmers and 27 rowers were enrolled in the study. 
128 blood samples from the general population matched 
by age and gender, were recruited for the control group 
(Table 4). DNA was extracted using standard methods 
and quantified using Qubit dsDNA High Sensitivity 
Assay Kit (Thermo Fisher). From 500 ng to 2 μg of 
DNA was treated with sodium bisulfite using the 
EpiTect 96 Bisulfite Kit (Qiagen, Hilden, Germany), 
following manufacturer’s guidelines. Specific CpG sites 
were analysed using previously described primers and 
methods [22]. Details of the analysed sites are presented 
in Table 5.  
 





























Statistical analyses and prediction of DNA 
methylation age 
 
Analyses were performed using PS IMAGO 4 (IBM 
SPSS Statistics 24). DNA methylation was measured in 
the two groups of 176 elite athletes plus 128 healthy 
counterparts of the age/gender matched control group at 
5 CpGs included in the age prediction model (Table 5). 
Methylation data was analysed using independent 
sample Student’s t test and the balanced distribution of 
age in the athlete and control groups confirmed with 
nonparametric Kolmogorov-Smirnov test. Age 
predictions were made with the method developed by 
Zbieć-Piekarska et al. [22] after remodelling with the 
artificial neural networks (ANN) approach applied in 
the study of Spólnicka et al. [23]. The training set of 
305 individuals from the above previous studies was 
used for the age predictions of the current study. The 
predicted age of athletes was compared with their true 
chronological age to calculate mean absolute error 
(MAE). Independent sample Student’s t test was used to 
compare mean predicted age and MAE. Age accelera-
tion (AA) - a measure of the discrepancy between 
methylation age and chronological age - was designated 
in the form of residuals calculated from linear 
regression analysis; where predicted age was treated as 
the dependent variable and chronological age the 
independent variable as described in [14]. Association 



























training with age acceleration was tested using linear 
regression, controlling for age and gender and in some 
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Locus CpG site Mean % of DNAmet  P value Mean % of DNAmet P value 
Females Males 
Athletes (N=64) Controls (N=47) Athletes (N=112) Controls (N=81) 
ELOVL2 C7 59.22 58.87 0.754 61.85 62.37 0.573 
MIR29B2C C1 79.86 81.45 0.179 79.19 80.01 0.341 
FHL2 C2 36.44 36.89 0.647 36.33 35.27 0.122 
TRIM59 C7 31.03 27.15 1.144x10-5 31.65 28.79 0.001 




5 CpG model      
Model Compared groups N MAE Std. Deviation P value 
Females Athletes  63 3.684 2.906 0.010 
Controls  47 2.501 1.822 
Endurance  27 3.233 2.472 0.149 
Controls 47 2.501 1.822 
Power 36 4.023 3.185 0.013 
Controls 47 2.501 1.822 
Males Athletes  112 3.042 2.428 0.013 
Controls 81 2.280 1.789 
Endurance  55 2.551 2.341 0.445 
Controls  81 2.280 1.789 
Power 57 3.515 2.437 0.002 
Controls 81 2.280 1.789 
One sample was removed from prediction analysis because of missing data in MIR29B2C C1. 
